---
schema_version: "secwatch.filing_event.v1"
accession: "0001516551-24-000064"
form_type: "8-K"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2024-07-03T23:59:59+00:00"
generated_at: "2026-05-31T23:28:28.975232+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience appoints Dr. Karen Smith to board; two directors resign effective Aug 1

## Summary
- Appoints Dr. Karen Smith MD, PhD, MBA, LLM to board; retainer $40k/yr plus committee fees and 40,000-share option.
- Drs. Keith Ward and Praveen Tyle resign from board effective Aug 1, 2024; no disagreement with company.
- Grants new General Counsel Brennen Brodersen inducement award: option for 60,000 shares and 15,000 RSUs.

## SEC filing metadata
- accession: 0001516551-24-000064
- form_type: 8-K
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2024-07-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000064/0001516551-24-000064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000064/skye-20240701.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516551-24-000064
- JSON: https://secwatch.observer/filing/0001516551-24-000064.json
- Plain text: https://secwatch.observer/filing/0001516551-24-000064.txt

## Key facts
- Executive change
  Keith Ward, PhD resigned as Director at Skye Bioscience, Inc..
  - Action: resigned
  - Role: Director
  source text: On July 1, 2024, each of Keith Ward, PhD and Praveen Tyle, PhD informed the Board of their intent to resign as a member of the Board, effective August 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000064/0001516551-24-000064-index.htm
- Executive change
  Karen L. Smith MD, PhD, MBA, LLM was appointed as Director at Skye Bioscience, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board approved an increase in its authorized size from eight to nine members and appointed Karen L. Smith MD, PhD, MBA, LLM to fill the vacancy created by such increase.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000064/0001516551-24-000064-index.htm
- Executive change
  Praveen Tyle, PhD resigned as Director at Skye Bioscience, Inc..
  - Action: resigned
  - Role: Director
  source text: On July 1, 2024, each of Keith Ward, PhD and Praveen Tyle, PhD informed the Board of their intent to resign as a member of the Board, effective August 1, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1516551/000151655124000064/0001516551-24-000064-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.